These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 9826481)

  • 1. Phantom hCG and phantom choriocarcinoma.
    Cole LA
    Gynecol Oncol; 1998 Nov; 71(2):325-9. PubMed ID: 9826481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
    Cole LA; Khanlian SA; Giddings A; Butler SA; Muller CY; Hammond C; Kohorn E
    Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of hCG in trophoblastic disease. The USA hCG reference service experience.
    Cole LA; Butler S
    J Reprod Med; 2002 Jun; 47(6):433-44. PubMed ID: 12092011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What we know about low-level hCG: definition, classification and management.
    Kohorn EI
    J Reprod Med; 2004 Jun; 49(6):433-7. PubMed ID: 15283049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies with choriocarcinoma and normal pregnancy serum chorionic gonadotrophin.
    Mwenda JM; Bambra CS; Onchiri F
    East Afr Med J; 1989 Jan; 66(1):2-9. PubMed ID: 2917494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inappropriate management of women with persistent low hCG results.
    Cole LA; Khanlian SA
    J Reprod Med; 2004 Jun; 49(6):423-32. PubMed ID: 15283048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. False diagnosis and needless therapy of presumed malignant disease in women with false-positive human chorionic gonadotropin concentrations.
    Rotmensch S; Cole LA
    Lancet; 2000 Feb; 355(9205):712-5. PubMed ID: 10703803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular heterogeneity of hCG in urine of the patients with trophoblastic diseases].
    Kitajima T; Mochizuki M; Nishimura R
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Mar; 43(3):297-303. PubMed ID: 1710641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors.
    Cole LA; Khanlian SA; Muller CY; Giddings A; Kohorn E; Berkowitz R
    Gynecol Oncol; 2006 Aug; 102(2):160-4. PubMed ID: 16631918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Persistent low levels of human chorionic gonadotropin in the serum: investigation and management].
    Faranesh R; Ben-David Y
    Harefuah; 2009 Feb; 148(2):101-3, 139. PubMed ID: 19627038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring therapy in trophoblastic diseases by radioimmunoassay of pregnancy-specific beta 1-glycoprotein and the beta subunit of human chorionic gonadotropin.
    Than GN; Csaba IF; Bohn H; Szabó DG; Szalmásy M; Menczer G
    Oncodev Biol Med; 1982; 3(4):315-23. PubMed ID: 6291007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoreactive human chorionic gonadotropin and its free beta subunit in serum and ascites of patients with malignant tumors.
    Hoermann R; Gerbes AL; Spoettl G; Jüngst D; Mann K
    Cancer Res; 1992 Mar; 52(6):1520-4. PubMed ID: 1540961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent low-level "real" human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma.
    Kohorn EI
    Gynecol Oncol; 2002 May; 85(2):315-20. PubMed ID: 11972394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Atypical choriocarcinoma. Analysis of 3 cases].
    Wang YE
    Zhonghua Fu Chan Ke Za Zhi; 1990 Nov; 25(6):355-7, 384. PubMed ID: 2282863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selecting an appropriate hCG test for managing gestational trophoblastic disease and cancer.
    Cole LA; Sutton JM
    J Reprod Med; 2004 Jul; 49(7):545-53. PubMed ID: 15305826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent low levels of serum hCG due to heterophilic mouse antibodies: an unrecognized pitfall in the diagnosis of trophoblastic disease.
    González Aguilera B; Syrios P; Gadisseur R; Luyckx F; Cavalier E; Beckers A; Valdes-Socin H
    Gynecol Endocrinol; 2016 Jun; 32(6):439-41. PubMed ID: 26792068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of metastatic gestational choriocarcinoma with oral methotrexate in a combat environment.
    Farley JH; Heathcock RB; Branch W; Larsen W; Homas D
    Obstet Gynecol; 2005 May; 105(5 Pt 2):1250-4. PubMed ID: 15863599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hCG assay in the treatment of trophoblastic disease.
    Pattillo RA; Hussa RO
    J Reprod Med; 1984 Nov; 29(11):802-12. PubMed ID: 6097684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous uterine perforation of choriocarcinoma with negative beta-human chorionic gonadotropin after chemotherapy.
    Xie C; Zheng L; Li ZY; Zhao X
    Med Princ Pract; 2011; 20(6):570-3. PubMed ID: 21986018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary pulmonary choriocarcinoma after human chorionic gonadotropin normalization following hydatidiform mole: a report of two cases.
    Maestá I; Leite FV; Michelin OC; Rogatto SR
    J Reprod Med; 2010; 55(7-8):311-6. PubMed ID: 20795344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.